Skip to main content
European Commission logo print header

Human hereditary deafness - identification of genes, molecular diagnostic tests, epidemiological data, understanding pathogenesis and search for therapies

Objectif

The project aims to address the needs of deaf patients 22.5 individual in the eu. By performing resaerech wich will lead to high quality genetic counselling and the discovery of curative treatements. To fulfil these expectations a number of human deafness will be isolated and moleculare daignastic test associated with a detailed clinicale description of the differnt gene defect will be developed. The major challenge i.e. the development nof new therapies will be tackled direclty as well as by elucuidating the underling dfective patwaays. To achieve this conplementary approaches will be set up and mouse and zebrafisch model for human daefness will be generated witch much effort on the connexin 26 gene defect 50% of congenitale deafness .the role of daefness gene in the susceptibility to environmentale causes of hearing loss .i.e. to noise and aminoglglycosides will be also analysed. Finally the consortium will produce epidemiologicale data on hereditary daefness in the eu.

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

INSTITUT PASTEUR
Contribution de l’UE
Aucune donnée
Adresse
Rue du Docteur Roux 25
75724 PARIS
France

Voir sur la carte

Coût total
Aucune donnée

Participants (5)